Experts Say More People Should Get Lung Cancer Screenings, and Sooner

A Rogel Cancer Center lung doctor discusses recommendations that annual screenings start at age 50 for current and former smokers with 20 “pack years”.

10:56 AM

Authors | Ian Demsky | Mary Clare Fischer

image of lung cancer scanning graphic image
Image by Stephanie King.

This story was updated on March 10, 2021.

A federal advisory group is recommending that annual lung cancer screenings start earlier and encompass people with more moderate smoking histories. The changes will essentially double the number people eligible for screenings nationwide — capturing more women and Black patients in particular.

The U.S. Preventive Services Task Force is recommending annual low-radiation CT scans for:

  • Adults aged 50-80 who have a smoked an average of a pack a day for 20 years, and who currently smoke or who have quit smoking within the last 15 years

  • Previously, annual scans were recommended for smokers with 30 "pack years" starting at age 55.

To better understand the thinking behind the recommendations and what they may mean for patients, the Michigan Health blog sat down with Douglas Arenberg, M.D., who heads the lung cancer screening program at the U-M Rogel Cancer Center.

"Lung cancer is the leading cause of cancer death in the U.S., with an average five-year survival rate of around 20%," Arenberg says. "And, like with most cancers, we know that we can achieve better outcomes for patients when lung cancer is detected at earlier stages."

This year, almost 236,000 Americans will be diagnosed with lung cancer and nearly 132,000 people will die of it, according to the American Cancer Society. Smoking is the largest risk factor — with smokers being 20 times more likely to develop the disease.

The screening recommendations were last updated in 2013 and new evidence has emerged since then, Arenberg notes.

Some of the key new data comes from a large scale study called the NELSON trial, which found that lung cancer deaths were reduced by nearly 25% among current and former smokers through the use of regular, low-dose CT screening, he adds.

SEE ALSO: Who Should Be Screened for Lung Cancer? The Evolving Science

Compared to other types of cancer, lung cancer screening adoption has been particularly low. A 2020 American Lung Association report found only 5.7% of people at high risk get screened.

One of the challenges has been that the recommendations aren't as simple as saying that everyone should get a colonoscopy when they turn 45, Arenberg notes.

"But while the guidelines remain more complex relative to screening guidelines for other types of cancer, the changes do two important things that have the potential to improve outcomes for thousands of people: significantly expand the number of eligible individuals and, supported by new evidence, reduce some health inequities by proportionally increasing the number of at-risk women and African Americans who are eligible for screening."

Worries about additional radiation

Many people are naturally concerned that the additional radiation exposure from the additional CT scans will increase their cancer risk.

"There is a risk, but it's extremely small — a decimal point with a lot of zeros after it," Arenberg says. "For long term smokers, which is who we're talking about, the theoretical risk from the tests is miniscule compared to the well-established risk of developing lung cancer."

The primary risk from increased screening actually comes from false positives, he adds.

Like with most cancers, we know that we can achieve better outcomes for patients when lung cancer is detected at earlier stages.
Douglas Arenberg, M.D.

"Unfortunately, there's no blood test or biomarker that's going to tell us if a suspicious spot on the lungs is benign or cancer," Arenberg says. "We sometimes have to do a biopsy to know for sure. And any time you are doing an invasive procedure on the lungs there is a small potential risk of complications."

Ever-improving imaging technology, however, is making it easier for doctors to monitor and evaluate suspicious lumps in a non-invasive manner — confirming, for example, if they are growing too slowly (or even too quickly) to likely be cancer, Arenberg notes.

With any type of cancer screening, the benefits must greatly outweigh the possible harms, he adds.

"The data the task force reviewed in making these recommendations suggest that expanding annual lung screenings could potentially help us catch a significant number of lung cancers at earlier stages, when they're easier to treat," Arenberg says.

Addressing disparities

Screening for lung cancer in those with lighter smoking histories and at an earlier age may also help improve racial disparities in screening eligibility, the task force notes. And because women also tend to smoke fewer cigarettes than men, women would make up a greater percentage of those the expanded guidelines would apply to.

Additionally, African Americans, especially those with more moderate smoking histories, are at higher risk than their white peers of developing lung cancer, the task force points out, though the reasons for the difference aren't entirely clear.

"So, the hope is that by lowering the age threshold and adding people with fewer pack years, there is also an opportunity to improve some of the racial disparities that are seen in lung cancer," Arenberg says.

Doctors talk about smoking history in terms of "pack years" — that is, smoking, on average, a pack of cigarettes a day for a year. It can also apply to those who smoke more over a shorter period of time (for example, two packs a day for half a year), or who smoke less for longer (half a pack a day for two years).


More Articles About: Cancer Care Cancer: Cancer Types lung cancer Lungs and Breathing
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
An unconscious woman lies on a hospital table while a clinician's glove is seen placing an oxygen mask over her nose and mouth
Health Lab
Hispanic patients with respiratory failure much more likely to be oversedated
Hispanic individuals who are hospitalized with respiratory failure are five times more likely than non-Hispanic patients to receive deep sedation while on a ventilator, according to a new study published in the Annals of the American Thoracic Society.
sketched out bacteria in a dish yellow and blue colors of U-M
Health Lab
Bacteria in the mouth linked to pulmonary fibrosis survival
Bacteria in the mouth may play a role in survival from idiopathic pulmonary fibrosis (IPF).
Gloved hands holding silicone chips used in cancer research
Health Lab
Is lung cancer treatment working? This chip can tell from a blood draw
Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.
Closeup of medical ventilator breathing tube
Health Lab
Patients on respiratory support in rural intermediate care units have higher death rates
Patients receiving ventilator life support in intermediate care units of rural hospitals had significantly higher death rates than patients in the same type of unit at urban hospitals, according to new study.
patient end of bed in hospital looking out window with stuffed animal on bed
Health Lab
Studying cells to improve medulloblastoma treatment
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.